KRAS and neoplasm: Among the identified somatic alterations, the simultaneous mutations in KRAS and SMAD4 caught our attention because (i) they have not been reported in uterine cervical cancers, and (ii) their persistence in T1−T3 indicates that this mutation signature contributed to the extreme radioresistance of the tumor.